AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Isla, D Rosell, R Sanchez, JJ Carrato, A Felip, E Camps, C Artal, A Gonzalez-Larriba, JL Azagra, P Alberola, J Martin, C Massuti, B
Citation: D. Isla et al., Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer, J CL ONCOL, 19(4), 2001, pp. 1071-1077

Authors: Valladares, JE Riera, C Gonzalez-Ensenyat, P Diez-Cascon, A Ramos, G Solano-Gallego, L Gallego, M Portus, M Arboix, M Alberola, J
Citation: Je. Valladares et al., Long term improvement in the treatment of canine leishmaniosis using an antimony liposomal formulation, VET PARASIT, 97(1), 2001, pp. 15-21

Authors: Solano-Gallego, L Riera, C Roura, X Iniesta, L Gallego, M Valldares, JE Fisa, R Castillejo, S Alberola, J Ferrer, L Arboix, M Portus, M
Citation: L. Solano-gallego et al., Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas - Evolution in the course of infection and after treatment, VET PARASIT, 96(4), 2001, pp. 265-276

Authors: Solano-Gallego, L Llull, J Arboix, M Ferrer, L Alberola, J
Citation: L. Solano-gallego et al., Evaluation of the efficacy of two leishmanins in asymptomatic dogs, VET PARASIT, 102(1-2), 2001, pp. 163-166

Authors: Munoz, I Gutierrez, A Gimeno, C Farga, A Alberola, J Solano, C Prosper, F Garcia-Conde, J Navarro, D
Citation: I. Munoz et al., Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneicstem cell transplant, J MED VIROL, 65(1), 2001, pp. 77-84

Authors: Alberola, J Tamarit, A Cardenoso, L Estelles, F Igual, R Navarro, D
Citation: J. Alberola et al., Longitudinal analysis of human cytomegalovirus glycoprotein B (gB)-specific and neutralizing antibodies in AIDS patients either with or without cytomegalovirus end-organ disease, J MED VIROL, 64(1), 2001, pp. 35-41

Authors: Solano-Gallego, L Morell, P Arboix, M Alberola, J Ferrer, L
Citation: L. Solano-gallego et al., Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology, J CLIN MICR, 39(2), 2001, pp. 560-563

Authors: Alberola, J Tamarit, A Igual, R Navarro, D
Citation: J. Alberola et al., Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection, J CLIN VIRO, 16(2), 2000, pp. 113-122

Authors: Solano-Gallego, L Llull, J Ramos, G Riera, C Arboix, M Alberola, J Ferrer, L
Citation: L. Solano-gallego et al., The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection, VET PARASIT, 90(1-2), 2000, pp. 37-45

Authors: Collado, A Algaba, F Caparros, J Alberola, J Montlleo, M Arano, P Villavicencio, H
Citation: A. Collado et al., Clear cell adenocarcinoma in a female urethral diverticulum, SC J UROL N, 34(2), 2000, pp. 136-138

Authors: Riera, C Valladares, JE Gallego, M Aisa, MJ Castillejo, S Fisa, R Ribas, N Carrio, J Alberola, J Arboix, M
Citation: C. Riera et al., Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate, VET PARASIT, 84(1-2), 1999, pp. 33-47

Authors: Ferrer, L Alberola, J Queralt, M Brazis, P Rabanal, R Llenas, J Puigdemont, A
Citation: L. Ferrer et al., Clinical anti-inflammatory efficacy of arofylline. a new selective phosphodiesterase-4 inhibitor, in dogs with atopic dermatitis, VET REC, 145(7), 1999, pp. 191-194

Authors: Orsola, A Diaz, I Caffaratti, J Izquierdo, F Alberola, J Garat, JM
Citation: A. Orsola et al., Staghorn calculi in children: Treatment with monotherapy extracorporeal shock wave lithotripsy, J UROL, 162(3), 1999, pp. 1229-1233

Authors: Alberola, J Tamarit, A Navarro, D
Citation: J. Alberola et al., Functional antibody response to human cytomegalovirus in immunocompetent and HIV-1 infected individuals with antibodies that inhibit virus penetration into cells and intercellular transmission of viral infection, J MED MICRO, 48(10), 1999, pp. 947-954
Risultati: 1-14 |